Sustained Improvements in Chorea Associated with Huntington Disease with Once-Daily Valbenazine: Interim Results from a Long-Term Open-Label Study

IntroductionIn a recently published Phase 3 trial (KINECT™-HD; NCT04102579), once-daily treatment with valbenazine significantly improved chorea versus placebo in adults with Huntington disease (HD). Individuals who completed KINECT-HD, along with de novo participants, were allowed to enroll in KINE...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	CNS spectrums 2024-10, Vol.29 (5), p.513-514
Hauptverfasser:	Stimming, Erin Furr, Claassen, Daniel O., Kayson, Elise, Goldstein, Jody, Hinton, Sean C., Klepitskaya, Olga, Zhang, Hui, Liang, Grace, Haubenberger, Dietrich
Format:	Artikel
Sprache:	eng
Schlagworte:	Abstracts Antipsychotics Huntingtons disease Psychotropic drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!